Technology Transfer

Before You Collaborate, You Should Partner with NCI TTC

NCI Technology Transfer Center staff

NCI Technology Transfer Center (TTC) staff (Frederick). Center: Tom Stackhouse, Ph.D., associate director; surrounded by (left to right) Rose Freel, Jasmine Yang, Heidi Bowman, Kevin Brand, Chris Sappington, Jeff Thomas, Mike Currens, Joseph Miles, Kathy Higinbotham, Donna Bialozor, and Karen Surabian.

By Karen Surabian, Thomas Stackhouse, and Jeffrey W. Thomas, Contributing Writers

As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations.

To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center (NCI TTC) can guide you through a tool box of agreements you may need for protecting your intellectual property (IP) and effectively managing your collaboration. 

Tags: 

Nineteen Patents Issued in 2012 for Inventions by Frederick Researchers

Scientific figure

The figure, representing US Patent 8,198,402 (Smoothened polypeptides and methods of use), illustrates the design principle used for generating the Hedgehog pathway inhibitors disclosed in the patent: folding the inhibitors through an interaction with the cellular membrane.  Membrane anchoring through lipidation allows the membrane to facilitate the folding of short protein fragments and the conversion of these fragments into potent inhibitors of the corresponding protein. Folding the inhibitors into the appropriate conformation is critical to their activity.

By Karen Surabian, Contributing Writer

Patents provide a period of exclusivity and are a way to exclude others from making, using, or selling an inventor’s novel technology. For the National Institutes of Health (NIH), patents are an incentive for an outside party to license, develop, and commercialize NIH technologies that will benefit public health, especially those that require substantial further development by an outside party, such as therapeutics and diagnostics.

Tags: 

New Website Helps You Find What You Need

Website screenshot

The NCI TTC’s redesigned website provides an inviting, user-friendly environment.

By Karen Surabian, Contributing Writer

The National Cancer Institute’s Technology Transfer Center (NCI’s TTC) recently launched a redesign of its website. New graphics, color scheme, and updated features provide a user-friendly environment for finding information related to technology transfer at NCI.

Tags: 

CRADAs: They're Not Just for NCI Anymore

Two hands shaking.

By Karen Surabian, Thomas Stackhouse, and Jeffrey Thomas, Contributing Writers, and Bruce Crise, Guest Writer

Advancing scientific discovery is increasingly dependent on diverse and innovative partnerships, and the Cooperative Research and Development Agreement (CRADA) is an essential tool for establishing partnerships. CRADAs allow a federal laboratory to enter into collaborative research and development (R&D) projects with outside parties (commercial or nonprofit).

Tags: 

Pages

Subscribe to RSS - Technology Transfer